Risk Factors for Carbapenem-resistant K. Pneumoniae Bloodstream Infection and Predictors of Mortality in Chinese Paediatric Patients

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2018 Jun 2

PMID 29855274

Citations 47

Authors

Ye Zhang

Ling-Yun Guo

Wen-Qi Song

Yan Wang

Fang Dong

Gang Liu

Affiliations

Soon will be listed here.

Abstract

Background: Bloodstream infections (BSI) caused by carbapenem-resistant K. pneumoniae (CRKP) are associated with high rates of morbidity and mortality. Early identification of patients at highest risk is very important. The aim of this study was to describe the clinical characteristics and mortality of K. pneumoniae BSI and to identify risk factors associated with CRKP BSI among paediatric patients.

Methods: From January 2011 to December 2014, a retrospective case-control study was conducted at Beijing Children's Hospital, China. Risk factors for CRKP BSI and for K. pneumoniae BSI-related death were evaluated. Patients with BSI caused by K. pneumoniae were identified from the microbiology laboratory database. Data regarding demographic, microbiological and clinical characteristics, therapy and outcome were collected from the medical records.

Results: A total of 138 patients with K. pneumoniae BSI were enrolled, including 54 patients with CRKP BSI and 84 patients with carbapenem-susceptible K. pneumoniae (CSKP) BSI. Most of the BSI (114; 82.6%) were healthcare-associated, while the rest (24; 17.4%) were community-acquired. Hematologic malignancies (odds ratio (OR):4.712, [95% CI: 2.181-10.180], P < 0.001) and previous cephalosporin administration (OR: 3.427, [95% CI: 1.513-7.766], P = 0.003) were found to be associated with the development of CRKP BSI. 28-day mortality of K. pneumoniae BSI was 8.7%. Mechanical ventilation (OR:9.502, [95% CI: 2.098-43.033], P = 0.003), septic shock (OR:6.418, [95% CI: 1.342-30.686], P = 0.020), and isolation of CRKP (OR:9.171, [95% CI: 1.546-54.416], P = 0.015) were independent risk factors for 28-day mortality of K. pneumoniae BSI.

Conclusion: Hematologic malignancies and previous cephalosporin administration were associated with the development of CRKP BSI, while mechanical ventilation, septic shock and CRKP infection were independent mortality predictors for K. pneumoniae BSI. More attention should be paid to CRKP BSI in the paediatric population.

Citing Articles

Characteristics and risk factors for infection and mortality caused by in patients with acute pancreatitis.

Chen J, Xiang Q, Wu J, Zheng X, Jiang X Front Public Health. 2025; 12:1533765.

PMID: 39897183 PMC: 11782239. DOI: 10.3389/fpubh.2024.1533765.

Retrospective Case-Control Study of Risk Factors for Carbapenem-Resistant Infection in Children in China.

Wang C, Feng L, Chen R, Chen Y Pathogens. 2025; 13(12.

PMID: 39770365 PMC: 11728686. DOI: 10.3390/pathogens13121106.

Carbapenem-Resistant Bacteremia in Pediatric Patients in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.

Ruvinsky S, Voto C, Roel M, Portillo V, Naranjo Zuniga G, Ulloa-Gutierrez R Antibiotics (Basel). 2025; 13(12.

PMID: 39766508 PMC: 11672711. DOI: 10.3390/antibiotics13121117.

Evaluation of elderly patients with bacteremia in the cardiology intensive care unit.

Kaya S, Kizmaz Y, Yigit F Medicine (Baltimore). 2024; 103(51):e40863.

PMID: 39705469 PMC: 11666138. DOI: 10.1097/MD.0000000000040863.

[A single-center analysis of pathogenic bacteria distribution and drug resistance in bacterial bloodstream infections among patients with hematological diseases].

Che M, Wang C, Liu H, Kong H, Li L, Song J Zhonghua Xue Ye Xue Za Zhi. 2024; 45(10):937-943.

PMID: 39622758 PMC: 11579750. DOI: 10.3760/cma.j.cn121090-20240603-00201.

References

Hu F, Guo Y, Zhu D, Wang F, Jiang X, Xu Y . Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016; 22 Suppl 1:S9-14. DOI: 10.1016/j.cmi.2016.01.001. View

Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I . Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013; 83(4):307-13. DOI: 10.1016/j.jhin.2012.10.012. View

Maltezou H, Kontopidou F, Katerelos P, Daikos G, Roilides E, Theodoridou M . Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. Pediatr Infect Dis J. 2012; 32(4):e151-4. DOI: 10.1097/INF.0b013e3182804b49. View

Navarro-San Francisco C, Mora-Rillo M, Romero-Gomez M, Moreno-Ramos F, Rico-Nieto A, Ruiz-Carrascoso G . Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge. Clin Microbiol Infect. 2012; 19(2):E72-9. DOI: 10.1111/1469-0691.12091. View

Gomez Rueda V, Zuleta Tobon J . Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med (Cali). 2014; 45(2):54-60. PMC: 4123582. View

Tian L, Tan R, Chen Y, Sun J, Liu J, Qu H . Epidemiology of bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016; 5:48. PMC: 5114729. DOI: 10.1186/s13756-016-0145-0. View

Bowers D, Huang V . Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE). Curr Infect Dis Rep. 2016; 18(12):48. DOI: 10.1007/s11908-016-0548-3. View

Montagnani C, Prato M, Scolfaro C, Colombo S, Esposito S, Tagliabue C . Carbapenem-resistant Enterobacteriaceae Infections in Children: An Italian Retrospective Multicenter Study. Pediatr Infect Dis J. 2016; 35(8):862-8. DOI: 10.1097/INF.0000000000001188. View

Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K . Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011; 17(12):1798-803. DOI: 10.1111/j.1469-0691.2011.03514.x. View

10.

Liu S, Chang H, Chia J, Kuo A, Wu T, Lee M . Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study. J Microbiol Immunol Infect. 2011; 45(2):113-9. DOI: 10.1016/j.jmii.2011.09.026. View

11.

Kumarasamy K, Toleman M, Walsh T, Bagaria J, Butt F, Balakrishnan R . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10(9):597-602. PMC: 2933358. DOI: 10.1016/S1473-3099(10)70143-2. View

12.

Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y . Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathog Glob Health. 2015; 109(2):68-74. PMC: 4455340. DOI: 10.1179/2047773215Y.0000000004. View

13.

Kim Y, Pai H, Lee H, Park S, Choi E, Kim J . Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother. 2002; 46(5):1481-91. PMC: 127143. DOI: 10.1128/AAC.46.5.1481-1491.2002. View

14.

Villegas M, Pallares C, Escandon-Vargas K, Hernandez-Gomez C, Correa A, Alvarez C . Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries. PLoS One. 2016; 11(4):e0154092. PMC: 4841576. DOI: 10.1371/journal.pone.0154092. View

15.

de Maio Carrilho C, Oliveira L, Gaudereto J, Perozin J, Urbano M, Camargo C . A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC Infect Dis. 2016; 16(1):629. PMC: 5096338. DOI: 10.1186/s12879-016-1979-z. View

16.

Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View

17.

Chen S, Feng W, Chen J, Liao W, He N, Wang Q . Spread of carbapenemase-producing enterobacteria in a southwest hospital in China. Ann Clin Microbiol Antimicrob. 2014; 13:42. PMC: 4236511. DOI: 10.1186/s12941-014-0042-4. View

18.

Xu L, Sun X, Ma X . Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017; 16(1):18. PMC: 5371217. DOI: 10.1186/s12941-017-0191-3. View

19.

Chang Y, Chuang Y, Siu L, Wu T, Lin J, Lu P . Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2014; 48(2):219-25. DOI: 10.1016/j.jmii.2014.05.010. View

20.

Zaoutis T, Goyal M, Chu J, Coffin S, Bell L, Nachamkin I . Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics. 2005; 115(4):942-9. DOI: 10.1542/peds.2004-1289. View